ZNTL
Zentalis Pharmaceuticals, Inc.
Recent 8-K filings for ZNTL
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 20:10 UTC earnings item 2.02item 7.01item 9.01
Zentalis Q1 2026 cash $211.8M; selects pivotal azenosertib dose; DENALI readout by year-end
source · ZNTL on sec.gov